WASHINGTON: India has reached out to prime American pharma companies in search of investment in the nation’s pharmaceutical and medical devices sector, which positive factors urgency in view of a devastating second wave of the coronavirus pandemic.
India’s Ambassador to the US Taranjit Singh Sandhu has held digital conferences with Alberta Bourla, the CEO of Pfizer, Thermo Fisher CEO Marc Casper, Bernd Brust, the chairman and CEO of Antylia Scientific, and Joseph Repp, the CEO of Pall Life Sciences.
He additionally had a name with Emmanuel Ligner, the CEO and president of Cytiva.
During his interactions with the pharma companies, Sandhu talked about that India is in search of to encourage investments into the pharmaceutical and medical devices sector.
India, he mentioned, has lately launched a manufacturing linked incentive scheme that may present the US companies new alternatives for investment.
“Discussed ways in which Pfizer could support healthcare efforts, including vaccines in India, and strengthen our pandemic response,” Sandhu said after his meeting with Bourla last week.
On Monday, Bourla had said that Pfizer was following with a deep concern the critical COVID-19 situation in India and his company was doing everything possible to provide support.
“Today now we have introduced we’re mobilising the most important humanitarian reduction effort in our firm’s historical past to assist the individuals of India struggle the vicious second wave of coronavirus that’s presently ravaging the nation,” he mentioned.
Among different issues, it introduced to donate sufficient of its medicines price USD 70 million to make sure that each COVID-19 affected person in each public hospital throughout India can have entry to them in the following 90 days free of cost.
“This effort has the potential to impact the lives of hundreds of thousands of patients,” Bourla said.
In his meeting with Thermo Fisher CEO Marc Casper, Sandhu underlined their important role in the fight against the pandemic, including expediting supplies to India of raw materials for Covishield vaccine as well as for essential medicines such as remdesivir.
Massachusetts-based Thermo Fisher is a company critical in the supply chain for biopharma products. It offers analytical instruments, laboratory equipment, chemicals and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
During his meeting with Repp, CEO of Pall Life Sciences, the Indian ambassador discussed strengthening supply chains, and expediting inputs for critical medicines such as remdesivir, and Novavax vaccine.
Pall biotech products have played a key role in life-saving drugs that range from Ebola vaccines to cancer-curing monoclonal antibodies. Its products have huge relevance given the current pandemic situation and are part of critical supply chains in the industry.
The company has an extensive network in India, including offices in Mumbai, Ahmedabad, Hyderabad, Chandigarh, Delhi, and Bangalore.
Sandhu in his call with Bernd Brust, the chairman and CEO of Antylia Scientific, appreciated the efforts of his company to ensure timely inputs for Covishield and Novavax vaccines.
Antylia Scientific is a global peristaltic and single-use bioprocessing solution expert, with a diverse portfolio of life sciences and diagnostic products for the pharma, biopharma, healthcare and environmental markets.
The ambassador also had a call with Emmanuel Ligner, the CEO and president of Cytiva which is a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics.